A Novel Genetic Screen Implicates Elm1 in the Inactivation of the Yeast Transcription Factor SBF by Manderson, Emily N. et al.
A Novel Genetic Screen Implicates Elm1 in the
Inactivation of the Yeast Transcription Factor SBF
Emily N. Manderson
., Mohan Malleshaiah
., Stephen W. Michnick*
De ´partement de Biochimie, Universite ´ de Montre ´al, Montreal, Quebec, Canada
Background. Despite extensive large scale analyses of expression and protein-protein interactions (PPI) in the model organism
Saccharomyces cerevisiae, over a thousandyeast genes remain uncharacterized. We have developed a novel strategy in yeast that
directly combines genetics with proteomics in the same screen to assign function to proteins based on the observation of genetic
perturbations of sentinel protein interactions (GePPI). As proof of principle of the GePPI screen, we applied it to identify proteins
involved in the regulation of an important yeast cell cycle transcription factor, SBF that activates gene expression during G1 and S
phase.Methodology/Principle Findings. TheprincipleofGePPIisthatifaproteinisinvolvedinapathwayofinterest,deletionof
the corresponding gene will result in perturbation of sentinel PPIs that report on the activity of the pathway. We created a
fluorescent protein-fragment complementation assay (PCA) to detect the interaction between Cdc28 and Swi4, which leads to the
inactivation of SBF. The PCA signal was quantified by microscopy and image analysis in deletion strains corresponding to 25
candidate genes that are periodically expressed during the cell cycle and are substrates of Cdc28. We showed that the serine-
threonine kinase Elm1 plays a role in the inactivation of SBF and that phosphorylation of Elm1 by Cdc28 may be a mechanism to
inactivate Elm1 upon completion of mitosis. Conclusions/Significance. Our findings demonstrate that GePPI is an effective
strategy to directly link proteins of known or unknown function to a specific biological pathway of interest. The ease in generating
PCA assays for any protein interaction and the availability of the yeast deletion strain collection allows GePPI to be applied to any
cellular network. In addition, the high degree of conservation between yeast and mammalian proteins and pathways suggest
GePPI could be used to generate insight into human disease.
Citation: Manderson EN, Malleshaiah M, Michnick SW (2008) A Novel Genetic Screen Implicates Elm1 in the Inactivation of the Yeast Transcription
Factor SBF. PLoS ONE 3(1): e1500. doi:10.1371/journal.pone.0001500
INTRODUCTION
Progress in large-scale experimental strategies in the last decade is
creating the framework for a molecular theory of the cell: from the
structure of the genome to the principles that organize biochemical
and gene regulatory networks. Genetic and proteomic methodolo-
gies are commonly applied in the model organism Saccharomyces
cerevisiae to decode genomic sequence information into a meaningful
understanding of protein function. For example, genetic screening
methods including synthetic genetic array analysis, diploid synthetic
lethality analysis by microarray, and epistatic miniarray profiles,
imply functional links between proteins by identifying pairs of
mutations in non-allelic genes that cause aggravating or alleviating
effects on growth [1,2,3,4]. However, the ability to demonstrate
interactions between two genes is restricted to those that result in a
measurable change in phenotype, such as fitness.
To maximize the knowledge that can be obtained from large-
scale genomic and proteomic experiments, focus is now being
placed on systems biology approaches in which datasets are
combined to learn more information than can be gathered from
any one dataset alone. Recently, combining genetic interactions
with protein-protein interaction (PPI) data has been shown to
generate valuable insight into relationships between protein
complexes and genetically defined epistasis groups [1]. In addition,
functional protein complex dynamics have been inferred from
comparison of PPI data with gene expression co-variation for
intrinsically dynamic processes, including replicative and respira-
tory cell cycles where timing of protein complex assembly and
gene expression are assumed to be tightly linked [5,6]. In these
efforts, PPI data are used as a tool of inference, whereas here we
show how dynamic PPIs can be used as direct and general sensors
of the activity of any cellular pathway to provide mechanistic
insights into the roles of proteins in a cellular process.
We present a novel screening strategy in which genetics and
proteomics are incorporated to detect genetic perturbations of
protein interactions (GePPI) in order to assign function to
previously uncharacterized or characterized proteins (Figure 1A).
The principle is that if a protein encoded by a candidate gene
plays a role in a biological pathway of interest, deletion of the gene
will result in perturbation of a sentinel PPI within the pathway.
The protein can be implicated in any step in the pathway
upstream of the interaction measured, wherein the change
propagates through the pathway resulting in a perturbation of
the PPI. Alternatively, a protein can be involved in a downstream
positive or negative feedback event that regulates the sentinel PPI.
The sentinel PPI is detected using protein-fragment complemen-
tation assays (PCA) (Reviewed in [7]), and perturbations are
measured by fluorescence microscopy and image analysis of the
PCA in selected yeast deletion strains. We previously showed that
fluorescent PCAs can detect spatial and/or temporal perturbations
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siRNAs, or hormones [8,9,10,11,12]. Perturbations of the sentinel
PPI could be due to a number of different processes including,
removal of a mediator or inhibitor of the interaction, changes in
the rate of protein synthesis or degradation, changes in protein
localization, or post-translational modifications.
To illustrate feasibility of the GePPI screen, we applied it to the
discovery of mechanisms underlying regulation of the yeast cell
cycle. A key aspect of this regulation involves proper timing of
activation and inactivation of transcription factors by the cyclin
dependent kinase, Cdc28. Cdc28 is activated by three G1-specific
cyclins, Cln1-3 and six mitotic B-type cyclins, Clb1-6. Two
heterodimeric transcription factors, SBF and MBF activate G1/S-
phase gene expression and each contains a common transactiva-
tion protein, Swi6 and a unique DNA binding protein, Swi4 and
Mbp1 respectively (Figure 1B). SBF is activated in G1 by Cln/
Cdc28 indirectly via phosphorylation of the SBF repressor Whi5
[13]. SBF is later inactivated at the G2/M transition by Clb/
Cdc28-dependent phosphorylation of Swi4 and Clb1 and Clb2 are
the principle cyclins responsible for this inactivation [14,15]
(Figure 1B). Similar mechanisms governing regulation of MBF
have not been elucidated; however, phosphorylation of Swi6 by
Clb6/Cdc28 leads to nuclear export during M-phase and may
contribute to inactivation of both transcription factors [16].
The interaction between Cdc28 and Swi4 was chosen as the
sentinel PPI in our GePPI screen since it represents the cell cycle
regulated event of SBF inactivation. We screened the Cdc28-Swi4
PCA in 25 candidate deletion strains and showed that the serine/
Figure 1. The GePPI screening strategy to identify proteins involved in the inactivation of SBF via phosphorylation by Clb/Cdc28. (A) A schematic
representation of the GePPI screening strategy. 1) A biological pathway of interest is selected and a PCA assay is created that detects one or more
sentinel PPIs of this pathway in wild-type yeast. In this example, protein A activates the sentinel interaction between proteins B and C, whereas
protein D inhibits the interaction via a negative feedback loop. 2) Candidate genes are selected and plasmids encoding the PCA fusion proteins for
each assay are transformed into the corresponding deletion strains. 3) Transformed deletion strains are screened in 96-well plates by fluorescence
microscopy and images are collected and processed using image analysis software. 4) Strains are selected for which the PCA signal is significantly
decreased or increased, as this type of analysis can be easily automated for yeast without the use of counter-stains that are required to identify
changes in sub-cellular localization. In this example, deletion of protein A results in a decrease in the PCA signal, whereas deletion of protein D results
in an increase in signal. (B) Regulation of SBF and MBF throughout the cell cycle. Activation of SBF involves phosphorylation of the SBF-associated
repressor Whi5 by Cln/Cdc28 during G1. Phosphorylation of Whi5 leads to its dissociation from SBF followed by nuclear export. Inactivation of SBF in
G2/M involves phosphorylation of Swi4 by Clb/Cdc28 activity. Regulation of MBF is less well understood but phosphorylation of Swi6 by Clb6/Cdc28
followed by Swi6 nuclear export may be a mechanism of inactivation of both SBF and MBF. The sentinel interaction between Cdc28 and Swi4 is
indicated by dashed box.
doi:10.1371/journal.pone.0001500.g001
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addition, we present data that suggest that phosphorylation of
Elm1 by Cdc28 is an important negative feedback event leading to
degradation of Elm1 upon completion of mitosis.
RESULTS AND DISCUSSION
In order to detect and localize PPIs in yeast, we adapted the
enhanced yellow fluorescent protein ‘Venus’ PCA [11,12] for use
in S. cerevisiae. With the yeast enhanced Venus PCA, we observed
the interaction between Cdc28 and Swi4 in the nuclei of dividing
cells (Figure 2). A direct physical interaction between Cdc28 and
Swi4 has not been previously reported, but was implied by the
finding that Swi4 co-immunoprecipitates with Clb2 even in the
absence of Swi6, and is phosphorylated by Clb2/Cdc28, whereas
Swi6 is not [14,15]. We also established assays and detected
nuclear interactions of Cdc28 with Swi6 and Mbp1 in vivo
(Figure 2). These PCAs were included as controls in the GePPI
screen based on the assumption that a perturbation specific to the
interaction between Clb/Cdc28 and Swi4 may or may not result
in a similar perturbation of the Cdc28-Swi6 PCA since Swi4 and
Swi6 form a complex. In contrast, the Cdc28-Mbp1 PCA should
not be perturbed since Clb1-4 are not required for suppression of
MBF activity and Mbp1 does not co-immunoprecipitate with
Clb2, suggesting MBF is inactivated through an alternate
mechanism [14,15].
In order to increase the efficiency of the GePPI screen, we took a
targeted approach to select candidate genes with an increased
likelihood of being involved in the inactivation of SBF based on
previous studies. We compared a list of 412 genes that are
periodically expressed during the cell cycle with no PPI of significant
reliability according to de Lichtenberg et al [5] to a list of 181 Cdc28
substrates identified in vitro [17]. Our rationale was that one or more
of these genes may function upstream of the inactivation of SBF by
Clb/Cdc28, and may, via phosphorylation by Cdc28 mediate
positive or negative feedback regulation of Cdc28 activity. Merging
of the two datasets generated a list of 25 non-essential proteins for
which the deletion strain was available, to which we added the three
components of SBF and MBF: Swi4, Swi6, and Mbp1; as well as the
principle cyclins involved inactivation and inactivation of SBF, Cln3
and Clb2 respectively (Table S1).
The Cdc28-Swi4 sentinel PCA, as well as the Cdc28-Swi6 and
Cdc28-Mbp1 PCAs were transformed into wild-type yeast and the
30 deletion strains. Each deletion strain was assigned a number to
createa‘‘blind’’assayinwhichallstepsofthescreenwereperformed
without prior knowledge of the gene name or function. The PCA
signal was quantified by fluorescence microscopy and image analysis
and the differences in average mean pixel intensity of each PCA
between wild-type and each deletion strain are presented in
Figure 3A and Figure S1. A dramatic perturbation of the Cdc28-
Swi4 sentinel PPI was observed in Delm1 and Dclb2 in that there was
Figure 2. Interactions between Cdc28 and the components of SBF and MBF. Representative images of wild-type yeast transformed with the Cdc28-
Swi4, Cdc28-Swi6 and Cdc28-Mbp1 yeast enhanced monomeric Venus (yEmVenus) PCAs. Fluorescence is detected in the nucleus for all three
interactions. No fluorescence is detected in cells transformed with the negative control PCA Swi4-Mbp1, mock cells transformed with empty plasmids,
or untransformed MatA cells.
doi:10.1371/journal.pone.0001500.g002
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(P=0.0002). The Cdc28-Swi6 PCA signal was also significantly
decreased in Delm1 (P=7.273e-05) but not Dclb2 (P=0.406). The
Cdc28-Mbp1 PCA was not significantly perturbed in either deletion
strain. Distributions of fluorescent intensity for the three PCAs in
MatA, Delm1 and Dclb2 are shown in Figure 3B.
Western blot analysis revealed that both Cdc28-VF[1] and
Swi4-VF[2] fusion proteins were detectable in Delm1 indicating
that in the absence of Elm1 the interaction between Cdc28 and
Swi4 is inhibited (Figure S2). In contrast, the Swi4 fusion protein
was not detectable in Dclb2, showing that it is unstable in these
cells and suggesting that cells reduce SBF activity by inducing Swi4
degradation. These results are consistent with the finding that
Clb1 and Clb2 are the cyclins mainly responsible for repression of
SBF regulated genes and that Clb2 is sufficient for repression of
SBF-induced genes in the absence of Clb1, Clb3 and Clb4 [14].
A significant decrease in the Cdc28-Swi6 PCA signal was
observed in Dswi4 (P=1.716e-05) and both PCA fusion proteins
Figure 3. The GePPI screen identifies Elm1 as involved in the regulation of SBF by Cdc28. (A) Changes in average mean pixel intensity for the three
PCAs: Cdc28-Swi4, Cdc28-Swi6 and Cdc28-Mbp1, in the 30 deletion strains. Dark red indicates increase in PCA signal, dark blue indicates decrease in
PCA signal, and black represents no change in PCA signal in a deletion strain relative to MatA. Light blue indicates significant decreases in signal
(P,0.0017). Genes are ordered according to time of peak expression during the cell cycle according to de Lichtenberg et al. [5] and the cell cycle
phase of expression is indicated. (B) Representative histograms showing cell population distributions of fluorescent intensity for the three PCAs used
in this study in Mat A, Delm1 and Dclb2.
doi:10.1371/journal.pone.0001500.g003
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of SBF and MBF [18,19], cells may decrease the inactivation of
MBF by inhibiting the phosphorylation of Swi6 by Clb6/Cdc28
which leads to nuclear export, in order to compensate for the lack
of SBF.
The results of the GePPI screen indicate that Elm1 plays an
important role in the inactivation of SBF via phosphorylation of
Swi4 by Clb/Cdc28. Elm1 is a serine/threonine kinase implicated
in cytokinesis, filamentous growth and polar bud growth based on
the elongated bud morphology of the deletion strain; however,
Elm1 function has not been associated with regulation of SBF
[20,21,22,23]. To better understand the relationship between
Elm1 and SBF activity, and the role of phosphorylation of Elm1 by
Cdc28, we performed subsequent analysis of MatA, Delm1, and
elmT551A, a strain in which we endogenously mutated the
threonine in the single Cdc28 consensus site found in Elm1 to
prevent its phosphorylation.
Decreased interaction between Cdc28 and Swi4 in Delm1
implies diminished inactivation of SBF. In support of this
hypothesis, we observed increased mRNA levels of the SBF-
specific gene, CLN1 in Delm1 (P=0.0118), but not the MBF-
specific gene, CDC45 (Figure 4 A,B). There was no significant
increase in CLN1 transcripts in elm1T551A in comparison to wild-
type cells (P=0.4228) (Figure 4 A,B), consistent with the finding
that the Cdc28-Swi4 PCA is not perturbed in the mutant strain
(Figure S3). SBF-specific targets are enriched in genes encoding
proteins responsible for cell morphogenesis and budding [18,19].
Thus, it is possible that the elongated bud phenotype of Delm1 is at
least partially due to a failure to inactivate SBF activated
transcription of genes that induce budding.
To further dissect the function of Elm1 and gain insight into the
role of phosphorylation of Elm1 by Cdc28, we compared the
phenotype of elm1T551A with that of Delm1 and wild-type cells.
The deletion strain displayed elongated buds, while in contrast a
small population of elm1T551A cells displayed an enlarged cell
phenotype, indicating that phosphorylation of threonine-551 is not
required for cytokinesis but may be required for timely progression
through G1 (Figure 5A). Both strains exhibited increased doubling
time in comparison to wild-type cells (Figure 5A). Flow cytometry
of synchronized cells showed that a small population of Delm1 cells
remained blocked in G2 (Figure 5A), consistent with the finding
that cells lacking Elm1 undergo a prolonged mitotic delay [22].
elm1T551A displayed a profile of DNA replication similar to wild-
type cells; however, there was an increase in the proportion of cells
remaining in G1 at 180 minutes after release, which can explain
its increased doubling time.
Elm1 was shown to localize to the bud neck of dividing yeast
when expressed from its own promoter [23]. We tagged both Elm1
and elm1T551A at their C-termini with full-length green
fluorescent protein (GFP) and observed both fusion proteins at
the bud neck of dividing yeast cells, indicating the mutation does
not affect the subcellular localization of the protein (Figure 5B).
Fluorescent PCA analysis demonstrated that Cdc28 interacted
with both Elm1 and elm1T551A predominantly at the bud neck
of dividing yeast and to a lesser extent in the cytoplasm, indicating
that Cdc28 is able to interact with both the wild-type and mutant
forms of the protein (Figure 5C). No physical interaction of
these two proteins has been reported, although a mutation in
ELM1 was shown to be synthetically lethal with the Cdc28C127Y
mutation that causes filamentous growth [24]. Our results are
consistent with the in vitro phosphorylation of Elm1 by Clb2/
Cdc28 [17] since Clb2 is the only cyclin that localizes to the bud
neck [25].
The majority of cells expressing elm1T551-GFP are larger than
wild-type cells and those expressing Elm1-GFP, similar to the
phenotype we observed for the elm1T551A strain, but more severe.
This observation suggests that the mutation may cause a mild delay
in G1, consistent with the increased doubling time and profile of
DNA replication observed for elm1T551A. We hypothesized that
phosphorylation of Elm1 by Cdc28 at threonine-551 is a signal for
Elm1 degradation at the end of mitosis and in the absence of this
phosphorylation signal, Elm1 levels and in turn Clb/Cdc28 activity
persist,therebyinhibitingprogressionthroughtherestrictionpointin
G1. To test this hypothesis we attempted to measure the levels of the
wild-type and mutant forms of Elm1 protein, but were unable to
detect the proteins using an anti-Elm1 antibody. A previous study
also failed to detect Elm1 by immunoblot analysis even when over-
expressed from the GAL promoter [26]. However, the authors were
abletodetectan Elm1fusionproteinthat wastagged with GST at its
N-terminus, leading them to speculate that Elm1 normally has a
short half-life and that the GST tag interfered with recognition of a
PEST motif found at residues 24–50, which is proposed to serve as a
signal for rapid intracellular proteolysis [26]. Similarly, we were able
to detect Elm1-GFP and elm1T551A-GFP with an anti-GFP
antibody in synchronized cells. We showed that Elm1-GFP was
present at low levels after release from arrest in G1, and then
increasedsteadilythroughoutthecellcycle.Incontrast,elm1T551A-
GFP was observed in the highest amount at the first time point after
release from G1 arrest (Figure 6A). The combination of the T551A
mutationandtheC-terminalGFPtagmayleadtostabilizationofthe
Elm1protein by interfering with recognition of a second PESTmotif
at residues 487-515 [26] (Figure 6B). This could also explain why the
enlarged cell phenotype of elm1T551A-GFP is more severe than that
of elm1T551A. Interestingly, a C-terminal deletion mutant of Elm1
(residues 1-420) that lacks threonine-551 displays higher kinase
activity than the wild-type protein [27].
Figure 4. SBF activity is increased in the Elm1 deletion strain. (A) A
representative result of semi-quantitative RT-PCR analysis of the SBF-
specific gene, CLN1, the MBF-specific gene, CDC45 and control gene, ACT1
in MatA, Delm1 and elm1T551A. RT=reverse transcriptase. (B) Average
expression of CLN1 and CDC45 normalized to ACT1 expression, over three
different experiments. Error bars represent standard deviation.
doi:10.1371/journal.pone.0001500.g004
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in the inactivation of SBF by Clb/Cdc28. Previous studies showed
that Elm1 is required for proper timing of Clb2/Cdc28 kinase
activity, that peak Elm1 protein levels correlate with maximal Clb2/
Cdc28 activity, and the phenotypic consequences of knocking-out
ELM1 are much more severe in a Clb2-dependent background
[22,23]. Swe1 inhibits Clb/Cdc28 activity by phosphorylation on
tyrosine-19 of Cdc28 and this inhibition seemsto be specific to Clb2/
Cdc28 [28]. The hyperpolarized growth and G2/M delay of Delm1 is
suppressed by deletion of SWE1, or mutation of Cdc28 such that it
cannot be phosphorylated on tyrosine-19 [21]. Elm1 is also required
for the hyperphosphorylation of Swe1 in vivo at the G2/M transition
[22]. Based on these findings and our results, we present a model in
which Elm1 functions upstream of Swe1 to relieve its inhibitory
action on Clb/Cdc28 activity, which is required for inactivation of
SBF (Figure 6C). Our results also suggest that phosphorylation of
Elm1 by Cdc28 is an important mechanism of inducing Elm1
degradation which in turn would lead to the suppression of Clb2/
Cdc28 activity upon completion of mitosis (Figure 6C).
Using the GePPI screen we identified one of 25 (4%) candidate
genes as playing a role in inactivation of SBF. Both Clb2 and Elm1
protein levels peak at the onset of mitosis, at the approximate time
that Swi4 interacts with the Clb2/Cdc28 kinase [15,23],
suggesting that selecting candidates expressed in the same cell
cycle phase(s) as the sentinel PPI may increase the success rate of a
GePPI screen involving a cell-cycle regulated event. In contrast to
large-scale screens that aim to test every gene or protein in an
organism, performing a small-scale screen by selecting candidate
genes based on prior knowledge can greatly increase the efficiency
and reduce the cost of the screening process.
We used the GePPI screen to provide new insights into the
regulation of an important cell cycle regulated event. The ability to
generate PCAs with fluorescent, luminescent or simple survival-
selection readouts [7] for any PPI in yeast means that one or a
series of specific sensors can be created to causally link any gene to
any cellular process, and to different steps in these processes. The
choice of PCAs to use in such screens will be dictated by the
problem being studied and specific advantages or disadvantages of
the different PCAs. For instance, the PCAs based on green
fluorescent protein variants reported here are useful in that they
can capture qualitative perturbations such as changes in cellular
locations of complexes in a gene-deleted strain. The fact that these
assays are irreversible, and are therefore kinetic traps of protein
complexes, means that they can capture transiently formed
complexes [11,29]. However, in some instances (but not many),
trapping complexes by the folded PCA reporter protein could
prevent detection, particularly of disruption of interactions.
Trapping is not a general problem with PCAs and in particular,
we have demonstrated that new classes of PCAs based on
luciferases are completely reversible; that is, dissociation of protein
complexes leads equally to unfolding and physical separation of
the complementary reporter protein fragments [30,31].
Individual PCAs combined with the availability of the deletion
strain collection [32] and titratable promoter alleles [33] or
hypomorphic alleles [2] to study essential genes in yeast means
that GePPI could be applied to any cellular pathway for which a
sentinel PPI reports on the state of the pathway in order to provide
testable mechanistic hypotheses into the function of genes. The
fact that over a thousand yeast genes are still listed as
uncharacterized in the Saccharomyces Gene Database emphasizes
Figure 5. Phenotypic characterization of the Elm1 deletion strain and the elm1T551A mutant strain. (A) Morphology, doubling time and DNA
replication of the three strains, MatA, Delm1, and elm1T551A. (B) Elm1-GFP and elm1T551A-GFP expressed from the endogenous ELM1 promoter
localize to the bud neck of dividing yeast cells. (C) Interaction between Cdc28 and both Elm1 and elm1T551A was detected at the bud neck of
dividing yeast using yEmVenus PCA.
doi:10.1371/journal.pone.0001500.g005
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insights into protein function [34]. GePPI is also complementary
to screens for genetic interactions by providing a direct way to
access the mechanistic origins of such interactions. The high
degree of conservation of proteins and pathways between yeast
and mammalian cells indicates GePPI could also be used to better
understand human diseases. For example, the mammalian tumor
suppressor LKB1, which is mutated in the Peutz-Jeghers familial
cancer syndrome, displays heterologous function to Elm1 in yeast
and therefore our results may provide insight into the mechanism
of cancer development in this disease [35].
METHODS
PCA
The enhanced yellow fluorescent protein ‘Venus’ PCA, was
adapted to allow visualization of PPIs in S. Cerevisiae. Alanine 206
of yeast enhanced Venus (yEVenus) was mutated to lysine (a
mutation that has been shown to prevent dimerization of GFP and
its variants [36]) by site-directed mutagenesis of pKT103 [37],
yielding yeast enhanced monomeric Venus (yEmVenus). Frag-
ment 1, (VF[1]: amino acids 2-158) and fragment 2, (VF[2]: amino
acids 159-240) of yEmVenus were amplified by PCR with the
addition of a (GGGGS)2 linker sequence at their 59 ends and
cloned into the p413ADHcen and p415ADHcen plasmids
respectively [38]. The sequences of genes of interest (without the
stop codon) were amplified by PCR from genomic DNA extracted
from MatA (BY4741) cells and cloned into the plasmids at the 59
end of the linker to generate fusion proteins.
Transformation of yeast with plasmids
Plasmids encoding VF[1] and VF[2] fusion proteins or empty
plasmids (mock cells) were co-transformed into competent MatA or
deletion strains (BY4741) [32]. Deletion strains were assigned a
number (DS1-30) to create a ‘‘blind’’ assay for the measurement of
PCA signal. Approximately 250 ng of each plasmid, 10 mLo f
competent cells, 60 mL PLATE solution (40% Polyethylene glycol
3350, 100 mM LiOAc, 10 mM Tris pH 7.5, 0.4 mM EDTA) and
8 mL of DMSO were mixed and incubated at 42uC for 20 min.
Yeast were then centrifuged at 2500 RPM for 3 min, the
supernatant was removed and the cells were resuspended in
500 mL of SD medium without amino acids or glucose.
Approximately 20 mL of this yeast suspension were then plated
on six-well plates containing SC agar, -histidine, -leucine, -lysine
and incubated at 30uC for 48–72 h to obtain individual colonies.
Positive colonies were verified by colony PCR.
Homologous recombination
The stop codon of Elm1 or elm1T551A was replaced with the
sequence of yeast enhanced green fluorescent protein 3 (yEGFP3)
with the (GGGGS)2 linker at its 59end by homologous recombina-
tion. Yeast were transformed as described above with the addition of
an incubation step of the DNA, yeast and PLATE solution at room
temperature for 30 min prior to the addition of DMSO and heat
shock. Following heat shock, 200 mL of YPD was added to the cells,
incubated at 30uC with shaking for 4 h and plated on YPD agar
containing 100 mg/mL nourseothricin to select individual colonies.
Positive colonies were verified by colony PCR.
Fluorescence Microscopy and Image Analysis
Yeast strains were grown in low fluorescence medium [37] (-his, -
leu, -lys) to an OD600 of 0.3 in order to have approximately the
same number of cells per sample at the time of analysis. 70 mLo f
each sample were added to individual wells of a 96-well glass
bottom plate (Molecular Machines) coated with Poly-L-Lysine mol
wt 30,000–70,000 (Sigma P2636). Fluorescence microscropy was
performed using an inverse Nikon TE 2000U microscope with
606objective and YFP filter cube (41028, Chroma Technologies).
Ten 16-bit images were captured with 750 ms exposure time for
each sample with a CoolSnap HQ CCD camera (Photometrics)
using Metamorph software at room temperature. Images were
analyzed with a macro written in ImageJ software (NIH). PCA
signal was measured by setting the threshold intensity to a
minimum of 225 to exclude the autofluorescence measured for
mock cells. Mean pixel intensity was measured for each particle of
a minimum size of 100 pixels after the threshold was applied. The
average of the mean intensity was calculated for all particles for
each sample. Images of Elm1-GFP and elm1T551A-GFP were
captured as described above except using a FITC filter cube
(31001, Chroma Technologies).
Elm1 mutagenesis
To mutate the threonine of the single Cdc28 consensus site (S/T-
P-X-K/R) of Elm1, the coding sequence and 421 bp of 59- and
533bp of 39 flanking sequence were PCR amplified from genomic
DNA and ligated into pRS306 [39] to generate pMNE1. The
T551A mutation was introduced into pMNE1 by site-directed
Figure 6. A proposed mechanism of Elm1 involvement in regulation
of SBF activity in yeast. (A) Western blot analysis of Elm1-GFP and
elm1T551A-GFP expressed from the endogenous promoter in synchro-
nized cells using Anti-GFP antibody. As a loading control, blots were
probed with anti-3-phosphoglycerate kinase (PGK) antibody. (B)
Schematic diagram of the Elm1 protein indicating the location of the
two PEST motifs in the N- and C-termini, the catalytic domain, and
threonine-551 of the single full consensus site of Cdc28 phosphoryla-
tion. (C) A proposed model whereby Elm1 functions upstream of Swe1
to relieve its inhibition of Clb/Cdc28 activity. Elm1 may also be
phosphorylated by Cdc28 in a negative feedback loop to induce its
degradation upon completion of mitosis. Hypothetical interactions are
indicated by dashed lines, solid lines represent interactions previously
reported in the literature.
doi:10.1371/journal.pone.0001500.g006
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ELM1 locus of BY4741 MatA yeast by the pop-in-pop-out strategy
following digestion with BglII [40].
RT-PCR
RNA was extracted from asynchronous yeast in logarithmic growth
phase using the MasterPure Yeast RNA Purification Kit (Epicentre
Biotechnologies)according to the manufacturer’s protocol. Genomic
DNA was digested with DNase at 37uC for 45 min. cDNA was
generated from 2 mg of RNA with Ready-To-Go RT-PCR Beads
(Amersham) according to manufacturer’s protocol. PCR was
performed on cDNA samples (including paired samples prepared
after inactivation of reverse transcriptase at 95uC for 10min to serve
as controls for the presence of genomic DNA) for each strain using
oligos designed to amplify close to the 39 end of each gene: CLN1-F:
CTCAAACGCAGGTATTCAGC and CLN1-R: GCGATATC-
GAAGACGCTCTA; CDC45-F: TGACGATACAGATGGA-
GAGGA and CDC45-R: AGGTCAGCTTCTCCAGGAAT;
ACT1-F: CCTACGTTGGTGATGAAGCT and ACT1-R:
GTCAGTCAAATCTCTACCGG. PCR conditions were as
follows: 95uC for 2 min, followed by 26 cycles of 95uC for 30 s,
57uC for 30 s, 72uC for 60 s, followed by 72uC for 10 min. PCR
products were electrophoresed on a 1.5% agarose gel and quantified
bydensitometry using Quantity One software(BioRad) todetermine
the ratio of CLN1 and CDC45 transcripts in comparison to the ACT1
control. The experiment was performed in triplicate and to
normalize the data between experiments, the average of all ratios
in each experiment was set to one.
Analysis of DNA Replication by Flow Cytometry
Yeast strains were grown to an OD600 of 0.2 in YPD and alpha
factor (Zymo Research) was added to a final concentration of
2 ug/mL and incubated at 30uC for 2 h to arrest cells in G1. Cells
were washed twice and resuspended in YPD+0.1 mg/mL Pronase
(Sigma) to release from arrest. 500 mL samples were collected
every 20 min and fixed in EtOH. Cells were incubated with
RNase solution (2 mg/mL RNase, 50 mM Tris-HCl pH 8.0) at
37uC for 1 h 45 min, followed by incubation in 200 mL5 5m M
HCl and 10 mg/mL pepsin at 37uC for 30 min. Finally, cells were
resuspended in 16propidium iodide (PI) solution (180 mM NaCl,
70 mM MgCl2, 75 uM PI, 100 mM Tris-HCl pH 7.5) and
incubated at 4uC overnight. DNA content was measured by flow
cytometry using the BD LSR II System (Beckton Dickinson) and
data was analyzed using FloJo Software (Treestar Inc.)
Western blotting
To detect Elm1 and elm1T551A endogenously tagged with full-
length yEGFP3, strains were grown to an OD600 of 0.1 in YPD
and then incubated at 30uC with 2 ug/mL of alpha factor (Zymo
Research) for 3 h. Cultures were washed twice and resuspended in
500 ml of fresh YPD. The first wash was considered as time zero.
Every 10 minutes, 25 ml aliquots were collected and centrifuged
at 4000 rpm for 3 minutes. The supernatant was removed, cells
were washed with 15 ml of sterile water, centrifuged again, and
pellets were immediately frozen at 280uC. Frozen pellets were
thawed on ice for 15 minutes and resuspended in 150 ml of yeast
extract buffer (25 mM Tris pH 7.4, 250 mM NaCl, 15 mM
MgCl2, 15 mM EDTA, 10% glycerol, 1 mM DTT, 1mM NaN3,
0.1% Triton X-100 and 0.25 mM sodium vanadate, 1 mM
phenylmethylsulfonyl fluoride, 5 mg/ml leupeptin , 5 mg/ml
pepstatin A and 16 Complete Protease Inhibitor Cocktail,
EDTA-free (Roche)). Cells were lysed by vortexing in the presence
of 200 ml of acid washed glass beads. Samples were centrifuged
and the supernatant was collected. Samples were migrated on 12%
gels, transferred to PVDF membrane (BioRad) and probed with
Anti-GFP, a mixture of two monoclonal antibodies (Roche
Applied Science). As a loading control, blots were stripped and
probed with yeast anti-3-phosphoglycerate kinase (PGK) mono-
clonal antibody (Molecular Probes).
Statistical Analysis
Comparisons of the PCA signal intensity between wild-type yeast
and candidate gene deletion strains were performed using The
Mann-Whitney U test. Two-sided P values were calculated and
the alpha level was set at 0.0017 after application of the Bonferroni
correction for multiple testing (0.05/30). In order to calculate P
values for the Cdc28-Swi4 PCA in Delm1 and Dclb2, the pixel
intensity was assigned the minimum value of 225. Comparisons of
RT-PCR results were performed using the unpaired T-test and
one-sided P values were calculated with an alpha value of 0.0125
(0.05/4).
SUPPORTING INFORMATION
Figure S1 Magnitude of Differences in Average Mean Pixel
Intensity Between MatA and Each Deletion Strain for the Three
PCAs: Cdc28-Swi4, Cdc28-Swi6 and Cdc28-Mbp1.
Found at: doi:10.1371/journal.pone.0001500.s001 (1.09 MB TIF)
Figure S2 Western Blot Analysis of PCA Fusion Proteins in
MatA, Selected Deletion Strains and Mock Cells transformed with
Empty Plasmids.
Found at: doi:10.1371/journal.pone.0001500.s002 (1.94 MB TIF)
Figure S3 Comparison of Signal Between MatA and
elm1T551A for the PCAs: Cdc28-Swi4, Cdc28-Swi6 and
Cdc28-Mbp1.
Found at: doi:10.1371/journal.pone.0001500.s003 (1.15 MB TIF)
Table S1 Candidate Genes Selected for the GePPI Screen.
Found at: doi:10.1371/journal.pone.0001500.s004 (0.03 MB
XLS)
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